Multiple Sclerosis News Today | Symptoms, Diagnosis, Treatments
Oct 3, 2024 · Get the latest multiple sclerosis news, patient views, and caregiver perspectives from one of the largest MS communities online.
Tecfidera with immune tolerizing cell therapy shows promise for MS
5 days ago · by Lindsey Shapiro, PhD October 11, 2024. Combining the approved medication Tecfidera (dimethyl fumarate) with targeted therapy using a patient’s own immune cells may eventually be a promising ...
Treatment of progressive MS hits milestones in recent years: Study
Feb 21, 2024 · The study, “ Clinical trials for progressive multiple sclerosis: progress, new lessons learned, and remaining challenges,” was published in The Lancet Neurology. MS has traditionally been ...
National MS Society updates Pathways to Cures Roadmap
Sep 11, 2024 · The original Pathways to Cures Roadmap, published in 2022, was created by the NMSS’s advisory committee and national board of directors, along with the Pathways to Cures task force, which ...
Top 10 MS stories of 2023 - Multiple Sclerosis News Today
Jan 2, 2024 · No. 1 – Coconut oil and green tea may improve balance and gait. Scientists in Spain conducted a pilot clinical trial (NCT03740295) that enrolled 51 adults with MS, all of whom were taking ...
Top 10 MS Stories of 2022 - Multiple Sclerosis News Today
Dec 30, 2022 · This is a list of the top 10 most-read articles we published this past year, with a brief description of each. We look forward to continuing to serve as a resource for the MS community in 2023.
Top 10 Multiple Sclerosis Stories of 2021
Jan 3, 2022 · The analysis included 296 people with newly diagnosed MS and 313 healthy controls. While no differences in common genetic variants of VDBP were observed between the groups, a sub-analysis of 77 MS ...
Adherence to PoNS device key to improving walking in MS: Study
6 days ago · That’s according to early data from PoNSTEP (NCT05437276), a real-world study that’s testing how adherence to the 14-week PoNS therapy regimen reflects on changes in gait, or walking ability ...
30 years after MS first treatable, challenges remain amid triumphs ...
Jun 13, 2023 · In the 30 years since, more than two dozen therapies have been approved to treat relapsing forms of MS, which are characterized by relapses, or periods where disease symptoms rapidly worsen or new ...
Stem Cell Therapy Shows 2-year Benefit for Progressive MS Patients
Dec 16, 2020 · An ongoing and placebo-controlled Phase 2 clinical trial (NCT03355365), which opened last year, is now investigating the safety and efficacy of repeat MSC-NP injections in progressive MS patients ...